HomeAI · summaries
Storia in 4 fonti
US tariff proposal wake-up call for Indian pharma to diversify, innovate: Experts
US pharma tariffs: Experts have urged a shift towards global diversification and prioritising innovation for Indian pharma to lessen market reliance. There are warnings that ensuring patient access to affordable medications should remain paramount.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
washingtonexaminer.com
Tariff India, and half of America’s medicine cabinet could disappear
The United States has built a decadeslong partnership with India, which supplies nearly half of all generic medicines that millions of Americans trust.
- ·
cnbc.com
U.S. to see higher generic drug prices thanks to tariffs, CEO of leading India pharma firm warns
CEO of Indian pharma company Dr Reddy's has warned that Trump's proposed tariffs on generic drugs will make them more expensive for patients.
